![Budget 2023 may offer Research Linked Incentive scheme for Indian pharma](https://images.assettype.com/fortuneindia%2F2021-12%2F919c1bf2-968d-46db-9535-d9f9a23bc54b%2FPharma_copy.jpg?rect=0,295,3532,1766&w=300&q=95)
Budget 2023 may offer Research Linked Incentive scheme for Indian pharma
RLI is expected to provide an extra financial cushion, in addition to the existing R&D sops available to pharmaceutical and biotech companies operating in India.
RLI is expected to provide an extra financial cushion, in addition to the existing R&D sops available to pharmaceutical and biotech companies operating in India.